Literature DB >> 35814885

A novel mutation of CYP4V2 gene associated with Bietti crystalline dystrophy complicated by choroidal neovascularization.

Xin-Yao Han1, Lin-Qi Zhang1, Ji-Yang Tang1, Lyu-Zhen Huang1, Ran Tang1, Jin-Feng Qu1.   

Abstract

AIM: To investigate the clinical characteristics and genetic features of a Bietti crystalline dystrophy (BCD) proband in a Chinese family.
METHODS: A Chinese female diagnosed with BCD complicated by bilateral choroidal neovascularization (CNV) and her parents underwent complete ophthalmic examinations, including fundus autofluorescence (AF), fundus photography (FP), fundus fluorescein angiography (FFA), visual field testing, full-field electroretinography (ERG), optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA). The sequencing of the CYP4V2 gene was performed to the whole family.
RESULTS: Bilateral tiny glittering crystal-like deposits and differing extent of atrophy of the retinal pigment epithelium (RPE) were found in the posterior pole of her fundus. The diffuse hypo-fluorescence shown on AF images and window defects shown on FFA both indicated the atrophy of the RPE and choriocapillaris. OCT showed the thinning of the RPE and choriocapillaris layer, ellipsoid zone (EZ) band defect and CNV in both eyes. OCTA images proofed bilateral type 2 CNV. The visual field test showed central and paracentral scotoma. ERG showed a slightly decreased b-wave in scotopic ERG. Gene sequencing identified three mutations of the CYP4V2 gene, c.802_807del, c.810delT, and c.1388G>A. The mutation c.1388G>A was a novel substitution mutation.
CONCLUSION: The novel mutation c.1388G>A may be a possible cause that could induce the clinical phenotype of BCD. International Journal of Ophthalmology Press.

Entities:  

Keywords:  Bietti crystalline dystrophy; CYP4V2 gene; choroidal neovascularization; retinal degeneration

Year:  2022        PMID: 35814885      PMCID: PMC9203464          DOI: 10.18240/ijo.2022.06.11

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.645


  43 in total

1.  Ranibizumab for subfoveal choroidal neovascularization in Bietti crystalline retinopathy.

Authors:  V Le Tien; K Atmani; G Querques; N Massamba; E H Souied
Journal:  Eye (Lond)       Date:  2010-08-27       Impact factor: 3.775

2.  Expression and characterization of CYP4V2 as a fatty acid omega-hydroxylase.

Authors:  Mariko Nakano; Edward J Kelly; Allan E Rettie
Journal:  Drug Metab Dispos       Date:  2009-08-06       Impact factor: 3.922

3.  Bietti crystalline dystrophy and choroidal neovascularization in childhood.

Authors:  Sabiha Gungor Kobat; Fatih Cem Gul; Elif Yusufoglu
Journal:  Int J Ophthalmol       Date:  2019-09-18       Impact factor: 1.779

4.  Detailed phenotypic and genotypic characterization of bietti crystalline dystrophy.

Authors:  Stephanie Halford; Gerald Liew; Donna S Mackay; Panagiotis I Sergouniotis; Richard Holt; Suzanne Broadgate; Emanuela V Volpi; Louise Ocaka; Anthony G Robson; Graham E Holder; Anthony T Moore; Michel Michaelides; Andrew R Webster
Journal:  Ophthalmology       Date:  2014-01-28       Impact factor: 12.079

Review 5.  Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors.

Authors:  Nicolas G Bazan
Journal:  Trends Neurosci       Date:  2006-04-03       Impact factor: 13.837

6.  Bietti's crystalline retinopathy.

Authors:  M Yuzawa; Y Mae; M Matsui
Journal:  Ophthalmic Paediatr Genet       Date:  1986-03

7.  The effect of ranibizumab and aflibercept treatment on the prevalence of outer retinal tubulation and its influence on retreatment in neovascular age-related macular degeneration.

Authors:  Attila Kovacs; Timea Kiss; Ferenc Rarosi; Gabor M Somfai; Andrea Facsko; Rozsa Degi
Journal:  BMC Ophthalmol       Date:  2018-11-14       Impact factor: 2.209

8.  AMPK modulation ameliorates dominant disease phenotypes of CTRP5 variant in retinal degeneration.

Authors:  Kiyoharu J Miyagishima; Ruchi Sharma; Malika Nimmagadda; Katharina Clore-Gronenborn; Zoya Qureshy; Davide Ortolan; Devika Bose; Mitra Farnoodian; Congxiao Zhang; Andrew Fausey; Yuri V Sergeev; Mones Abu-Asab; Bokkyoo Jun; Khanh V Do; Marie-Audrey Kautzman Guerin; Jorgelina Calandria; Aman George; Bin Guan; Qin Wan; Rachel C Sharp; Catherine Cukras; Paul A Sieving; Robert B Hufnagel; Nicolas G Bazan; Kathleen Boesze-Battaglia; Sheldon Miller; Kapil Bharti
Journal:  Commun Biol       Date:  2021-12-09

9.  Multimodal imaging features and genetic findings in Bietti crystalline dystrophy.

Authors:  Wei Wang; Wei Chen; Xinyue Bai; Ling Chen
Journal:  BMC Ophthalmol       Date:  2020-08-15       Impact factor: 2.209

10.  PSCs Reveal PUFA-Provoked Mitochondrial Stress as a Central Node Potentiating RPE Degeneration in Bietti's Crystalline Dystrophy.

Authors:  Zhao Zhang; Bin Yan; Fei Gao; Qing Li; Xiaohong Meng; Peikai Chen; Lei Zhou; Wen Deng; Cheng Li; Weiyi Xu; Shuo Han; Hong Feng; Yaping Li; Junhui Chen; Zhengqin Yin; Can Liao; Hung-Fat Tse; Aimin Xu; Qizhou Lian
Journal:  Mol Ther       Date:  2020-07-25       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.